This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.

Kirsten Axelsen

Senior Policy Advisor
Kirsten Axelsen | Life Sciences | Charles River Associates

Kirsten works with leaders in healthcare helping to develop business practices that lead to greater access to affordable medicines, positive public perception, and sustained profitability to support investment in the next generation of innovation.

Kirsten sat on the leadership team of Pfizer Inc’s $30 billion global innovative pharmaceutical business, where she led Strategy and Business Evaluation. Previously, Kirsten led Pfizer’s Global Policy team. She is an Aspen Institute Health Innovator Fellow and a senior advisor to Charles River Associates.

Kirsten recently climbed Mt. Kilimanjaro to raise $1.6 million for cancer research with a team of biotech CEOs and investors.

Capabilities
Kirsten Axelsen | Life Sciences | Charles River Associates
Capabilities

Selected engagements

  • 01
    Evaluating unintended impacts of the IRA’s Medicare Drug Price Negotiation Program on small and large molecule medicines
    A leading pharmaceutical company sought support from CRA Life Sciences experts in analyzing the patient, health system, and innovation implications of the IRA's
    View engagement
  • 02
    Developing an evidence-based framework for sustainable NCCP funding and address global disparities in implementation and outcomes
    A leading pharmaceutical company sought CRA Life Sciences experts to gain a deeper understanding of how governments plan and finance national cancer strategies
    View engagement

Latest insights

Recent events

Credentials

Get In Touch
Kirsten Axelsen
kaxelsen@crai.com